Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in epidermolysis bullosa patients A. Chiou,S. Choi, M. Barriga, Y. Dutt-Singkh,D. Solis, J. Nazaroff, I. Bailey-Healy,S. Li, M. Joing,P. Kwon,J. TangJournal of Investigative Dermatology（2018）引用 24|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
